Short-acting ß2 agonists should be used as the initial treatment for COPD patients to relieve breathlessness.
With certain short-acting benzodiazepines it is not possible to achieve a smooth decline in blood and tissue concentrations.
Its insertion is stimulating but may be attenuated by using local anesthetic, a small bolus of propofol or a short acting opioid.
Seretide Evohaler should not be used to treat acute asthma symptoms for which a fast and short acting bronchodilator is required.
The patient should be instructed to seek medical advice if short-acting relief bronchodilator treatment becomes less effective or they need more inhalations than usual.
